CAMLINFINE103.71

Camlin Fine Sciences Limited

· Chemicals
₹ CrorePeersCLEANDEEPAKNTRBAYERCROPTIRUMALCHMATULSHKPAUSHAKLTDANURASMcap ₹1,992 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Returns
Return on Common Equity-10.82-15.892.762.76
Return on Assets-5.37-7.811.011.01
Return on Capital Employed-0.3812.252.662.66
Return on Invested Capital-0.3310.452.270.66
Margins
EBITDA Margin4.5812.496.204.61
Operating Margin-0.298.662.092.09
Incremental Operating Margin278.62-190.76
Pretax Margin-6.152.94-1.95-3.63
Net Income Margin-6.50-9.491.370.03
Net Income to Common Margin-5.75-8.341.600.32
FCF Margin4.86-0.941.421.42
Additional
Effective Tax Rate-5.670.141.351.10
Sustainable Growth Rate-10.82-15.892.762.76
Incremental Operating Margin %278.62-190.76-18.48
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.